← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2010Last known activity
Feb 12, 2025
Timeline
2000s
- Jul 1, 2009
Ragon Institute of MGH, MIT and Harvard— Founded
Drugs by trial phase (22 distinct, 10 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT06617091CollaboratorPhase 1Feb 12, 2025
- NCT06135974CollaboratorEarly Phase 1Oct 19, 2023
- NCT05393193CollaboratorPhase 4Jul 4, 2022
- NCT03526848CollaboratorPhase 1Jun 5, 2018
- NCT03307915CollaboratorPhase 1Mar 5, 2018
- NCT03205917CollaboratorPhase 1Oct 23, 2017
- NCT02960581Study chairPhase 1Nov 1, 2016
- NCT02960581CollaboratorPhase 1Nov 1, 2016
- NCT02431325CollaboratorPhase 2Dec 1, 2015
- NCT02369406CollaboratorPhase 2/Phase 3Feb 1, 2015
- NCT01215149CollaboratorPhase 1Oct 1, 2010
Details
- Founded
- Boston, MA, US Jul 1, 2009
- Last known activity
- Feb 12, 2025